Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

332.15
Delayed Data
As of Feb 16
 -1.03 / -0.31%
Today’s Change
313.53
Today|||52-Week Range
543.55
-11.65%
Year-to-Date
Top Research Reports for Novo Nordisk, TJX Companies & Cigna
Feb 16 / Zacks.com - Paid Partner Content
Regeneron (REGN) Tops Q4 Earnings & Sales
Feb 08 / Zacks.com - Paid Partner Content
Sustainable Growth Advisers, LP Buys Yum Brands Inc, Walt Disney Co, Regeneron Pharma...
Feb 13 / GuruFocus News - Paid Partner Content
Sanofi (SNY) Q4 Earnings Lag on Weak Diabetes/Vaccines Sales
Feb 07 / Zacks.com - Paid Partner Content
Wall Street Falls Tuesday Morning
Feb 13 / GuruFocus News - Paid Partner Content
REGN vs. ALXN: Which Stock is Poised for Better Q4 Earnings?
Feb 07 / Zacks.com - Paid Partner Content
Handling Your Finances at Any Age: Cramer's 'Mad Money' Recap (Monday 2/12/18)
Feb 12 / TheStreet.com - Paid Partner Content
Will Regeneron (REGN) Disappoint Investors in Q4 Earnings?
Feb 05 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings & Revenues Top, Eylea Sales Grow
Feb 08 / Zacks.com - Paid Partner Content